1. Home
  2. EML vs ABOS Comparison

EML vs ABOS Comparison

Compare EML & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

N/A

Current Price

$25.15

Market Cap

152.9M

ML Signal

N/A

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

N/A

Current Price

$2.87

Market Cap

197.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EML
ABOS
Founded
1858
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
197.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
EML
ABOS
Price
$25.15
$2.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
9.7K
342.1K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
N/A
EPS
1.04
N/A
Revenue
$248,970,345.00
N/A
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$1.21
52 Week High
$29.91
$3.60

Technical Indicators

Market Signals
Indicator
EML
ABOS
Relative Strength Index (RSI) 46.94 51.98
Support Level $24.18 $2.13
Resistance Level $27.16 $3.02
Average True Range (ATR) 1.25 0.19
MACD -0.23 -0.04
Stochastic Oscillator 29.76 33.33

Price Performance

Historical Comparison
EML
ABOS

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: